Global Advanced Parenteral Drug Delivery Market Research Report 2023

Publication ID:

PB502232869

Publication Date:

February 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Parenteral drug delivery systems are those devices that inject the medicine doses other than oral route. Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment. Overall, the technique seeks to optimize therapeutic index by enabling immediate drug due to the systemic pool in desired quantities.
Highlights
The global Advanced Parenteral Drug Delivery market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market is expected to have the largest market share due to increasing acceptance of technologically advanced healthcare systems and rising patient awareness levels. European market expected to follow North American market. Asia pacific regional market is expected to be the most lucrative due to increasing penetration, greater untapped opportunity and rapidly improving healthcare infrastructure in emerging economies of China and India.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Advanced Parenteral Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Parenteral Drug Delivery.
The Advanced Parenteral Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Advanced Parenteral Drug Delivery market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Advanced Parenteral Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
Segment by Type
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
Segment by Application
Government Hospitals
Private Hospitals and Clinics
Healthcare Organizations
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Advanced Parenteral Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Advanced Parenteral Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Advanced Parenteral Drug Delivery Market Overview
1.1 Product Overview and Scope of Advanced Parenteral Drug Delivery
1.2 Advanced Parenteral Drug Delivery Segment by Type
1.2.1 Global Advanced Parenteral Drug Delivery Market Value Comparison by Type (2023-2029)
1.2.2 Prefillable Syringes
1.2.3 Injectors Cartridges
1.2.4 Hypodermic Syringes
1.2.5 IV Catheters
1.2.6 Other Parenteral Delivery Devices
1.3 Advanced Parenteral Drug Delivery Segment by Application
1.3.1 Global Advanced Parenteral Drug Delivery Market Value by Application: (2023-2029)
1.3.2 Government Hospitals
1.3.3 Private Hospitals and Clinics
1.3.4 Healthcare Organizations
1.3.5 Others
1.4 Global Advanced Parenteral Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Advanced Parenteral Drug Delivery Revenue 2018-2029
1.4.2 Global Advanced Parenteral Drug Delivery Sales 2018-2029
1.4.3 Global Advanced Parenteral Drug Delivery Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Advanced Parenteral Drug Delivery Market Competition by Manufacturers
2.1 Global Advanced Parenteral Drug Delivery Sales Market Share by Manufacturers (2018-2023)
2.2 Global Advanced Parenteral Drug Delivery Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Advanced Parenteral Drug Delivery Average Price by Manufacturers (2018-2023)
2.4 Global Advanced Parenteral Drug Delivery Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Advanced Parenteral Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Advanced Parenteral Drug Delivery, Product Type & Application
2.7 Advanced Parenteral Drug Delivery Market Competitive Situation and Trends
2.7.1 Advanced Parenteral Drug Delivery Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Advanced Parenteral Drug Delivery Players Market Share by Revenue
2.7.3 Global Advanced Parenteral Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Advanced Parenteral Drug Delivery Retrospective Market Scenario by Region
3.1 Global Advanced Parenteral Drug Delivery Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Advanced Parenteral Drug Delivery Global Advanced Parenteral Drug Delivery Sales by Region: 2018-2029
3.2.1 Global Advanced Parenteral Drug Delivery Sales by Region: 2018-2023
3.2.2 Global Advanced Parenteral Drug Delivery Sales by Region: 2024-2029
3.3 Global Advanced Parenteral Drug Delivery Global Advanced Parenteral Drug Delivery Revenue by Region: 2018-2029
3.3.1 Global Advanced Parenteral Drug Delivery Revenue by Region: 2018-2023
3.3.2 Global Advanced Parenteral Drug Delivery Revenue by Region: 2024-2029
3.4 North America Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.4.1 North America Advanced Parenteral Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Advanced Parenteral Drug Delivery Sales by Country (2018-2029)
3.4.3 North America Advanced Parenteral Drug Delivery Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Advanced Parenteral Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Advanced Parenteral Drug Delivery Sales by Country (2018-2029)
3.5.3 Europe Advanced Parenteral Drug Delivery Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.6.1 Asia Pacific Advanced Parenteral Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Advanced Parenteral Drug Delivery Sales by Country (2018-2029)
3.6.3 Asia Pacific Advanced Parenteral Drug Delivery Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Advanced Parenteral Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Advanced Parenteral Drug Delivery Sales by Country (2018-2029)
3.7.3 Latin America Advanced Parenteral Drug Delivery Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Advanced Parenteral Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Advanced Parenteral Drug Delivery Sales by Country (2018-2029)
3.8.3 Middle East and Africa Advanced Parenteral Drug Delivery Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Advanced Parenteral Drug Delivery Sales by Type (2018-2029)
4.1.1 Global Advanced Parenteral Drug Delivery Sales by Type (2018-2023)
4.1.2 Global Advanced Parenteral Drug Delivery Sales by Type (2024-2029)
4.1.3 Global Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2029)
4.2 Global Advanced Parenteral Drug Delivery Revenue by Type (2018-2029)
4.2.1 Global Advanced Parenteral Drug Delivery Revenue by Type (2018-2023)
4.2.2 Global Advanced Parenteral Drug Delivery Revenue by Type (2024-2029)
4.2.3 Global Advanced Parenteral Drug Delivery Revenue Market Share by Type (2018-2029)
4.3 Global Advanced Parenteral Drug Delivery Price by Type (2018-2029)
5 Segment by Application
5.1 Global Advanced Parenteral Drug Delivery Sales by Application (2018-2029)
5.1.1 Global Advanced Parenteral Drug Delivery Sales by Application (2018-2023)
5.1.2 Global Advanced Parenteral Drug Delivery Sales by Application (2024-2029)
5.1.3 Global Advanced Parenteral Drug Delivery Sales Market Share by Application (2018-2029)
5.2 Global Advanced Parenteral Drug Delivery Revenue by Application (2018-2029)
5.2.1 Global Advanced Parenteral Drug Delivery Revenue by Application (2018-2023)
5.2.2 Global Advanced Parenteral Drug Delivery Revenue by Application (2024-2029)
5.2.3 Global Advanced Parenteral Drug Delivery Revenue Market Share by Application (2018-2029)
5.3 Global Advanced Parenteral Drug Delivery Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Advanced Parenteral Drug Delivery Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Advanced Parenteral Drug Delivery Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Advanced Parenteral Drug Delivery Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Hoffmann-La Roche
6.4.1 Hoffmann-La Roche Corporation Information
6.4.2 Hoffmann-La Roche Description and Business Overview
6.4.3 Hoffmann-La Roche Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hoffmann-La Roche Advanced Parenteral Drug Delivery Product Portfolio
6.4.5 Hoffmann-La Roche Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AstraZeneca Advanced Parenteral Drug Delivery Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Baxter Advanced Parenteral Drug Delivery Product Portfolio
6.6.5 Baxter Recent Developments/Updates
6.7 Dickinson
6.6.1 Dickinson Corporation Information
6.6.2 Dickinson Description and Business Overview
6.6.3 Dickinson Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dickinson Advanced Parenteral Drug Delivery Product Portfolio
6.7.5 Dickinson Recent Developments/Updates
6.8 Boston Scientific
6.8.1 Boston Scientific Corporation Information
6.8.2 Boston Scientific Description and Business Overview
6.8.3 Boston Scientific Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Boston Scientific Advanced Parenteral Drug Delivery Product Portfolio
6.8.5 Boston Scientific Recent Developments/Updates
6.9 Bristol-Myers Squibb
6.9.1 Bristol-Myers Squibb Corporation Information
6.9.2 Bristol-Myers Squibb Description and Business Overview
6.9.3 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Product Portfolio
6.9.5 Bristol-Myers Squibb Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GlaxoSmithKline Advanced Parenteral Drug Delivery Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Advanced Parenteral Drug Delivery Description and Business Overview
6.11.3 Novartis Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novartis Advanced Parenteral Drug Delivery Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Becton
6.12.1 Becton Corporation Information
6.12.2 Becton Advanced Parenteral Drug Delivery Description and Business Overview
6.12.3 Becton Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Becton Advanced Parenteral Drug Delivery Product Portfolio
6.12.5 Becton Recent Developments/Updates
6.13 AptarGroup
6.13.1 AptarGroup Corporation Information
6.13.2 AptarGroup Advanced Parenteral Drug Delivery Description and Business Overview
6.13.3 AptarGroup Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.13.4 AptarGroup Advanced Parenteral Drug Delivery Product Portfolio
6.13.5 AptarGroup Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Advanced Parenteral Drug Delivery Industry Chain Analysis
7.2 Advanced Parenteral Drug Delivery Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Advanced Parenteral Drug Delivery Production Mode & Process
7.4 Advanced Parenteral Drug Delivery Sales and Marketing
7.4.1 Advanced Parenteral Drug Delivery Sales Channels
7.4.2 Advanced Parenteral Drug Delivery Distributors
7.5 Advanced Parenteral Drug Delivery Customers
8 Advanced Parenteral Drug Delivery Market Dynamics
8.1 Advanced Parenteral Drug Delivery Industry Trends
8.2 Advanced Parenteral Drug Delivery Market Drivers
8.3 Advanced Parenteral Drug Delivery Market Challenges
8.4 Advanced Parenteral Drug Delivery Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂